Send the exact assignment or rubric from your classroom and a custom sample written to it lands in 24 to 48 hours, the first one free. HCM-5010 is TESU’s Organization of the Healthcare Value Chain course. It examines the U.S. healthcare value chain in four modules: the overall system, intermediaries such as insurers, pharmacy benefit managers and group purchasing organizations, manufacturers of drugs and devices, and providers. Searches like "hcm 5010 module 3 assignment example", "HCM5010 sample paper", and "HCM-5010 module samples" land on this page.
What HCM-5010 is really about
The course takes its frame from Burns and the Wharton School’s The Health Care Value Chain, which describes the industry as a chain of producers, purchasers and providers linked by intermediaries. That frame changes how familiar problems look. High drug prices become a question about rebates negotiated between manufacturers and pharmacy benefit managers; supply costs in hospitals become a question about group purchasing organizations and physician preference items; and provider consolidation becomes a question about bargaining power with insurers. The graduate version at TESU expects you to use current examples, since the sectors have changed a great deal since the textbook was written.
Four modules mean an eight-week pace with little slack. Module 1 surveys the system as a whole, and Modules 2 to 4 each analyze one sector: intermediaries, manufacturers and providers. Alongside the written assignments, students prepare a team presentation for a synchronous event on proposals to lower prescription drug costs and their effects on every sector, and the course ends with a final paper of 2,000 to 2,750 words on how technology has changed each part of the chain. The best papers use the same lens throughout: who pays whom, for what, and with what incentive.
What HCM-5010’s assessments ask for
Four written assignments, one per module, ask you to analyze the system or a sector with evidence: its structure, its main players, how money moves through it and what that means for cost, quality and access. Four discussions, a graded team presentation in Week 8 with an ungraded outline, and the final paper complete the work. Mentors expect graduate-level sources, such as peer-reviewed health policy research, government reports and industry data, and they expect you to take a position rather than describe from a distance.
Where students lose points in HCM-5010
Papers lose points by describing a sector without explaining its incentives. A paragraph that lists the three largest pharmacy benefit managers is description; a paragraph that explains how rebates tied to list prices can reward higher list prices is analysis. Another frequent loss is relying on the textbook’s examples from two decades ago when the course wants today’s market. Students also forget the links between sectors: a change in hospital purchasing affects device makers, and a change in drug pricing law affects insurers and pharmacies. Trace at least one effect up or down the chain in every paper.
The HCM-5010 drawers
HCM-5010 Module 1 assignment example
Written assignment 1: the $4.9 trillion U.S. health system of 2023 mapped onto Burns's value chain of payers, fiscal and product intermediaries, manufacturers and providers, following one hospital's purchase of a hip implant and one patient's prescription to show where cost and bargaining power accumulate. Full sample paper, read it free.
HCM-5010 Module 2 assignment example
Written assignment 2: pharmacy benefit managers, group purchasing organizations and drug wholesalers analyzed for concentration, revenue models and conflicts of interest, using the FTC's 2024 interim report on the three largest PBMs and a national survey of hospital purchasing alliances, with recommendations on transparency and delinked fees. Full sample paper, read it free.
HCM-5010 Module 3 assignment example
Written assignment 3: drug, biotech and device makers analyzed for research costs (median $985 million versus $2.6 billion estimates), patent-based pricing power, the different regulatory paths for devices, and Medicare's first negotiated prices taking effect in 2026, with the effects traced up and down the value chain. Full sample paper, read it free.
HCM-5010 Module 4 assignment example
Written assignment 4: hospitals and physician groups at the bottom of the chain, analyzed for horizontal mergers (monopoly hospitals priced 12 percent above markets with four rivals), hospital purchases of physician practices (prices up 14.1 percent), facility fees and the claimed benefits of integration, with recommendations for site-neutral payment and merger review. Full sample paper, read it free.
Your classroom shows something else?
Thomas Edison State University revises courses; module counts and deliverables shift between terms. Send what your classroom shows and the desk matches it exactly.
Using a HCM-5010 sample the right way
Send the written assignment prompt for your module, and a first custom sample comes back free inside 24-48h. Notice how each section names who pays whom and why, uses current data with dates, and follows at least one effect across sectors. Use that analytic habit in your own paper, with your own sources and conclusions.
How these samples are written
These samples read the value chain the way the course does: who pays whom, for what and with what incentive, with current data dated and the textbook’s model applied rather than repeated. A custom request is written to your module’s prompt and sources.
HCM-5010 questions, answered
What is the healthcare value chain?
A model that describes the industry as manufacturers who produce drugs, devices and supplies, intermediaries who purchase and distribute them, and providers who deliver care, with payers financing the whole chain.
How current should HCM-5010 sources be?
As current as the topic allows; the textbook supplies the framework, but drug pricing, insurer markets and provider consolidation change quickly, so recent government reports and peer-reviewed studies carry the analysis.
What is the HCM-5010 final project?
A paper of 2,000 to 2,750 words on how increased use of technology has affected each sector of the U.S. healthcare value chain, including benefits and unintended consequences.